Vanguard Group Inc Zai Lab LTD Transaction History

Vanguard Group Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$30.21 - $48.1 $88.6 Million - $141 Million	-2,932,743 Reduced 81.22%	677,919 $22.5 Million
Q4 2022 Feb 10, 2023	BUY	$22.28 - $38.71 $1.28 Million - $2.23 Million	57,582 Added 1.62%	3,610,662 $111 Million
Q3 2022 Nov 14, 2022	BUY	$34.2 - $51.69 $43 Million - $65 Million	1,258,009 Added 54.81%	3,553,080 $122 Million
Q2 2022 Aug 12, 2022	BUY	$23.14 - $49.68 $917,177 - $1.97 Million	39,636 Added 1.76%	2,295,071 $79.6 Million
Q1 2022 May 13, 2022	BUY	$27.77 - $64.4 $1.53 Million - $3.55 Million	55,132 Added 2.51%	2,255,435 $99.2 Million
Q4 2021 Feb 14, 2022	BUY	$54.9 - $105.21 $962,342 - $1.84 Million	17,529 Added 0.8%	2,200,303 $138 Million
Q3 2021 Nov 12, 2021	BUY	$105.0 - $178.37 $5.67 Million - $9.63 Million	53,990 Added 2.54%	2,182,774 $230 Million
Q2 2021 Aug 13, 2021	BUY	$125.11 - $180.0 $266 Million - $383 Million	2,128,784 New	2,128,784 $377 Million

121

46.7M

223K

588K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.59B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.